Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2065551000001119 | Berotralstat dihydrochloride | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2065561000001116 | Berotralstat dihydrochloride (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Berotralstat dihydrochloride | Is a | Substance with kallikrein inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Berotralstat 150mg capsules | Has specific active ingredient | True | Berotralstat dihydrochloride | Inferred relationship | Existential restriction modifier | |
| Orladeyo 150mg capsules (BioCryst Ireland Ltd) 28 capsule 4 x 7 capsules | Has specific active ingredient | True | Berotralstat dihydrochloride | Inferred relationship | Existential restriction modifier | |
| Berotralstat 150mg capsules 28 capsule | Has specific active ingredient | True | Berotralstat dihydrochloride | Inferred relationship | Existential restriction modifier | |
| Orladeyo 150mg capsules (BioCryst Ireland Ltd) | Has specific active ingredient | True | Berotralstat dihydrochloride | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR